WallStreetZenWallStreetZen

NASDAQ: IMMX
IMMIX Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
IMMIX Biopharma earnings were -$29.4M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest IMMX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$10.7M, up 40.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IMMX reported annual earnings of -$29.4M, with 36.2% growth.

IMMX earnings history

Current Revenue
$0.0
Current Earnings
-$29.4M
Current Profit Margin
0%

IMMX Return on Equity

Current Company
-101.2%
Current Industry
-31.4%
Current Market
28.9%
IMMX's Return on Equity (-101.2%)... subscribe to Premium to read more.
High Return on Equity Performance

IMMX Return on Assets

Current Company
-73.4%
Current Industry
-9.6%
IMMX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMMX announces earnings.

IMMX Return on Capital Employed

Current Company
-31.04%
Current Industry
-3.7%
IMMX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMMX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMMX-$29.04M-$29.44MN/A-$0.89
CBIO-$158.55M-$162.08MN/A-$11.82
UPB-$142.69M-$143.44MN/A-$2.66
XOMA$34.69M$18.52M+13.29%$1.53
FDMT-$132.48M-$140.11MN/A-$2.42
View Top Biotech Stocks

IMMIX Biopharma Earnings Reports & History FAQ

What were IMMIX Biopharma's earnings last quarter?

On IMMX's earnings call on Invalid Date, IMMIX Biopharma (NASDAQ: IMMX) reported Q4 2025 earnings per share (EPS) of -$0.28, up 75% year over year. Total IMMX earnings for the quarter were -$10.69 million. In the same quarter last year, IMMIX Biopharma's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.

Is IMMIX Biopharma profitable or losing money?

As of the last IMMIX Biopharma earnings report, IMMIX Biopharma is currently losing money. IMMIX Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$29.44 million, a 36.21% increase year over year.

What was IMMX's earnings growth in the past year?

As of IMMIX Biopharma's earnings date in Invalid Date, IMMIX Biopharma's earnings has grown year over year. IMMX earnings in the past year totalled -$29.44 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.